Arvinas (ARVN)
(Delayed Data from NSDQ)
$32.37 USD
+0.77 (2.44%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $32.39 +0.02 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ARVN 32.37 +0.77(2.44%)
Will ARVN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ARVN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARVN
Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
ARVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Is Arvinas (ARVN) Stock a Solid Choice Right Now?
Is a Surprise Coming for Arvinas (ARVN) This Earnings Season?
Other News for ARVN
Arvinas price target lowered by $17 at Citi, here's why
Arvinas (ARVN) Shares Cross Below 200 DMA
Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer
Arvinas appoints Randy Teel Chief Business Officer
Analysts’ Top Healthcare Picks: Quanterix (QTRX), Intuitive Surgical (ISRG)